TSX-V:KNE • CA4838092084
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KANE BIOTECH INC (KNE.CA).
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 2.668M 65.97% | 149K -94.42% | 2.081M 1,296.58% | |
| EBITDA YoY % growth | -3.1M 33.97% | -3.119M -0.59% | -3.705M -18.78% | |
| EBIT YoY % growth | -3.364M 31.12% | -3.357M 0.19% | -3.923M -16.85% | |
| Operating Margin | -126.06% | -2,253.29% | -188.52% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
KANE BIOTECH INC (KNE.CA) will report earnings on 2026-03-19.